CREDOPHAR
Timeline
32 events since 2012Board
Capital
Filings
Financial
Establishments
Address
20122014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 26 days late
2025
Back to profit net €51,670 The net result is €51,670, after one loss-making year.
Annual accounts 2024 filed PDFabbreviated format · 1 day before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0849730193
2024
Weakest financial year net -€182,309 The net result drops to -€182,309, the lowest from 2014 to 2025. It recovers the following year.
Permanent representatives: Wouter Coppens and Mario DebelGeneral meeting of 23-06-20233 points ▸
- General meeting, 23-06-2023
- Permanent representative, Wouter Coppens (vertegenwoordiger in uitoefening van mandaat van commissaris)
- Permanent representative, Mario Debel
- The deed holds 1 more point.
Annual accounts 2023 filed PDFabbreviated format · 6 days before the deadline
2023
Equity above €2m equity €2.1m ▲10.8% After 9 profitable years in a row, equity reaches €2.1m.
Annual accounts 2022 filed PDFabbreviated format · 29 days late
2022
Registered office moved from Lier to Sint-Denijs-WestremNew registered office: Kortrijksesteenweg 1091 bus B, 9051 Sint-Denijs-Westrem · Previous registered office: Kelderveld 37/2, 2500 Lier · Appointment: PwC Bednjfsrevisoren (statutory auditor) · Board meeting of 24-10-20228 points ▸
- General meeting, 01-12-2021
- Auditor appointment, PwC Bednjfsrevisoren (statutory auditor)
- Board meeting, 24-10-2022
- Registered-office move, Kortrijksesteenweg 1091 bus B, 9051 Sint-Denijs-Westrem
- Board composition, MD Consult (director)
- Board composition, Aquitania (director)
- Permanent representative, Mario Debel
- Permanent representative, Anja Imschoot
Annual accounts 2021 filed PDFabbreviated format · 25 days late
2021
Highest result from 2014 to 2025 net €686,939 ▲103% The operating result of €951,124 and the net result of €686,939 are both a record.
Liquidity more than doubled current ratio 4.18 The current ratio rises from 1.81 to 4.18. Short-term debt falls from €1.2m to €483,687.
Amendment of the articlesGeneral meeting of 28-10-20212 points ▸
- General meeting, 28-10-2021
- 200 shares
- The deed holds 3 more points.
2 directors appointed, 2 resignationsResignations: Joeri Van den Acker and Barbara Van den Acker · Appointments: MD Consult BV and Aquitania BV · Permanent representatives: Mario Debel and Anja Imschoot · General meeting of 30-03-20217 points ▸
- General meeting, 30-03-2021
- Director resignation, Joeri Van den Acker
- Director resignation, Barbara Van den Acker
- Director appointment, MD Consult BV
- Director appointment, Aquitania BV
- Permanent representative, Mario Debel
- Permanent representative, Anja Imschoot
Demerger: CREDOPHAR splits off to Pharma BoulevardReappointments: Joeri VAN dEN ACKER (director) and Barbara VAN dEN ACKER (director) · 200 shares · Capital of €24,900, 200 shares · General meeting of 29-03-202116 points ▸
- General meeting, 29-03-2021
- 200 shares
- Power of attorney, Yves De Vil
- Registered office clause, Kelderveld 37 bus 2, 2500 Lier
- Director reappointment, Joeri VAN dEN ACKER (director (not named in the articles))
- Director reappointment, Barbara VAN dEN ACKER (director (not named in the articles))
- Capital, €24,900, 200 shares
- Barbara VAN dEN ACKER holds 60 shares (30%)
- Joeri VAN dEN ACKER holds 140 shares (70%)
- Share issue, €182
- Barbara VAN dEN ACKER holds 55 shares (30%)
- Joeri VAN dEN ACKER holds 127 shares (70%)
- Share issue, €837
- Barbara VAN dEN ACKER holds 251 shares (29.99%)
- Joeri VAN dEN ACKER holds 586 shares (70.01%)
- Accounting effect, 01-01-2021
- The deed holds 20 more points.
Annual accounts 2020 filed PDFabbreviated format · 150 days before the deadline
Demerger proposal: CREDOPHAR splits off to PHARMA BOULEVARDPermanent representatives: Joeri Van den Acker and Barbara Van den Acker · Capital of €24,900, 200 shares · Barbara Van den Acker holds 60 shares (30%)13 points ▸
- Board composition, Barbara Van den Acker (director)
- Board composition, Joeri Van den Acker (director)
- Board composition, JOBA (director)
- Board composition, VIOS (director)
- Permanent representative, Joeri Van den Acker
- Permanent representative, Barbara Van den Acker
- Capital, €24,900, 200 shares
- Barbara Van den Acker holds 60 shares (30%)
- Joeri Van den Acker holds 140 shares (70%)
- Capital, €100,000, 100 shares
- Barbara Van den Acker holds 55 shares (30%)
- Joeri Van den Acker holds 127 shares (70%)
- Accounting effect, 01-01-2021
- The deed holds 18 more points.
2020
Equity above €1m equity €1.0m ▲48.6% After 6 profitable years in a row, equity reaches €1.0m.
Annual accounts 2019 filed PDFabbreviated format · 62 days late
2019
Equity above €500,000 equity €697,017 ▲59.4% After 5 profitable years in a row, equity reaches €697,017.
Annual accounts 2018 filed PDFabbreviated format · 33 days late
2018
Equity above €200,000 equity €437,345 ▲145% After 4 profitable years in a row, equity reaches €437,345.
Annual accounts 2017 filed PDFabbreviated format · 176 days before the deadline
2017
Equity above €150,000 equity €178,738 After 3 profitable years in a row, equity reaches €178,738.
Annual accounts 2016 filed PDFabbreviated format · 31 days late
Annual accounts 2016 filed PDFabbreviated format · 5 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 4 days late
2015
Back to profit net €16,095 The net result is €16,095, after one loss-making year.
Annual accounts 2014 filed PDFabbreviated format · 19 days before the deadline
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank